Ads
related to: pfizer covid vaccine
Search results
AstraZeneca pulls its COVID-19 vaccine from the European market
WSB-TV 2 Atlanta· 6 days agoLONDON — (AP) — The pharma giant AstraZeneca has requested that the European authorization for its ...
Aaron Rodgers gives bizarre interview to Tucker Carlson talking anti-vax, Biden, and ‘demonic’ UFOs
The Independent via Yahoo News· 8 hours agoBut these issues remain rare in overall terms, and their impact would likely be dwarfed by the...
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Benzinga via AOL· 1 day agoPfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by...
Will withdrawal of AstraZeneca vaccine affect your next COVID booster jab?
Yahoo News UK· 7 days agoAppointments were offered from April and UK Health Security Agency advice on bookings set out the ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 15 hours agoDuring the March quarter, the U...projection. The company also raised its sales outlook for the...
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 6 days agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 21 hours agoWhy does Sanofi want the Novavax COVID vaccine? The Novavax COVID-19 vaccine, which is called...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 15 hours agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 15 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...